RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vanessa Rivera-Amill to Immunoglobulin G

Back to Details
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Immunoglobulin G.
Vanessa Rivera-Amill
Connection Strength
0.459
Immunoglobulin G
  1. Madewell ZJ, Graff NE, Lopez VK, Rodriguez DM, Wong JM, Maniatis P, Medina FA, Mu?oz JL, Briggs-Hagen M, Adams LE, Rivera-Amill V, Paz-Bailey G, Major CG. Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico. Sci Rep. 2024 12 28; 14(1):30743.
    View in: PubMed
    Score: 0.205
  2. Medina FA, Vila F, Adams LE, Cardona J, Carrion J, Lamirande E, Acosta LN, De Le?n-Rodr?guez CM, Beltran M, Grau D, Rivera-Amill V, Balmaseda A, Harris E, Madewell ZJ, Waterman SH, Paz-Bailey G, Whitehead S, Mu?oz-Jord?n JL. Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination. J Clin Microbiol. 2024 Oct 16; 62(10):e0059324.
    View in: PubMed
    Score: 0.200
  3. Camprub?-Ferrer D, Torres-Vel?squez B, Perez Padilla J, Wong J, S?nchez-Gonz?lez L, Munoz-Jordan JL, Rodriguez Vargas DM, Rivera-Amill V, Adams LE, Paz-Bailey G. Severity of Primary and Secondary Dengue Virus 1 Infections: A Hospital-Based Study in Puerto Rico, 2012-2014. Am J Trop Med Hyg. 2025 Aug 06; 113(2):361-365.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support